Immunocore Holdings Ratios (2022-2025) | IMCR

Ratios Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 99.60%99.42%99.57%99.71%99.65%97.74%99.44%99.61%99.11%98.94%99.51%
EBT Margin -35.05%-28.15%1.13%-36.55%-34.15%-13.44%7.59%-29.53%6.48%-9.90%0.29%
EBIT Margin -26.89%-23.02%-21.81%-24.30%-37.57%-21.24%-10.59%-23.14%-3.85%-15.18%-6.92%
EBITDA Margin -21.98%-17.14%-21.66%-0.82%-33.39%-14.15%14.93%-31.36%6.07%-3.90%-3.44%
Operating Margin -26.89%-23.02%-21.81%-24.30%-37.57%-21.24%-10.59%-23.14%-3.85%-15.18%-6.92%
Net Margin -35.60%-28.47%1.40%-28.12%-34.72%-15.42%10.89%-28.28%5.31%-10.51%-0.19%
FCF Margin 13.79%-2.26%15.23%-26.44%-7.12%30.69%25.30%-20.86%0.15%26.08%-5.02%
Efficiency
Inventory Average 4.33M3.81M3.99M4.98M6.12M6.13M5.56M
Assets Average 795.49M1,008.68M1,054.00M1,047.07M1,018.76M1,055.20M1,092.44M
Equity Average 364.19M359.34M368.48M369.27M369.60M383.48M392.52M
Invested Capital 338.90M368.84M359.53M359.14M377.83M360.72M378.48M388.48M396.56M
Asset Utilization Ratio 0.330.280.280.300.330.340.35
Leverage & Solvency
Interest Coverage Ratio -11.76-10.80-10.71-13.03-8.18-3.74-1.98-2.76-1.20-4.89-2.36
Debt to Equity 0.140.131.221.221.031.081.031.010.99
Debt Ratio 0.090.080.440.430.360.390.380.360.36
Equity Ratio 0.640.620.360.350.350.360.370.360.36
Times Interest Earned -11.76-10.80-10.71-13.03-8.18-3.74-1.98-2.76-1.20-4.89-2.36
Valuation
Enterprise Value 2,331.46M2,377.49M2,900.83M2,527.22M2,935.00M2,405.52M835.30M655.80M655.59M648.48M693.50M938.21M
Market Capitalization 2,733.94M2,377.49M2,900.83M2,527.22M3,377.62M3,238.34M1,694.89M1,557.08M1,475.97M1,485.52M1,576.33M1,830.56M
Return Ratios
Return on Sales -0.22%-0.23%-0.20%-0.16%-0.16%-0.06%-0.06%-0.08%
Return on Capital Employed -0.11%-0.09%-0.09%-0.08%-0.05%-0.05%-0.05%
Return on Invested Capital -0.18%-0.19%-0.16%-0.18%-0.12%-0.11%
Return on Assets -0.08%-0.05%-0.04%-0.05%-0.02%-0.02%-0.03%
Return on Equity -0.17%-0.15%-0.13%-0.14%-0.06%-0.05%-0.07%